Main results
After the treatment for HL . | Patients total N = 67 ABVD n = 37 . | Controls total N = 134 ABVD matched n = 74 . | P . |
---|---|---|---|
Women having started a pregnancy | |||
ABVD group, n (%) | 20 (54) | 36 (48) | .59 |
In the entire cohort, n (%) | 36 (53.7) | 73 (54.5) | .92 |
Pregnancies | |||
ABVD group | 32 | 67 | .41 |
In the entire cohort | 58 | 136 | .2 |
Births | |||
ABVD group | 26 | 52 | .48 |
In the entire cohort | 48 | 104 | .35 |
Women wanting children who have had at least 1 birth in ABVD group | 81% | n.a. | |
Median time to pregnancy (y), median (min-max) | 4.8 (3.1-6.6) | 6.8 (5-8.7) | .21 |
Difficulty getting pregnant, n (%) | 9 (13) | 25 (19) | <.001 |
Use of MAP, n (%) | 7 (11) | 7 (5) | .125 |
Age at the onset of menopause (y), median (min-max) | 44.4 (36-55) | 51.5 (36.2-59) | .006 |
After the treatment for HL . | Patients total N = 67 ABVD n = 37 . | Controls total N = 134 ABVD matched n = 74 . | P . |
---|---|---|---|
Women having started a pregnancy | |||
ABVD group, n (%) | 20 (54) | 36 (48) | .59 |
In the entire cohort, n (%) | 36 (53.7) | 73 (54.5) | .92 |
Pregnancies | |||
ABVD group | 32 | 67 | .41 |
In the entire cohort | 58 | 136 | .2 |
Births | |||
ABVD group | 26 | 52 | .48 |
In the entire cohort | 48 | 104 | .35 |
Women wanting children who have had at least 1 birth in ABVD group | 81% | n.a. | |
Median time to pregnancy (y), median (min-max) | 4.8 (3.1-6.6) | 6.8 (5-8.7) | .21 |
Difficulty getting pregnant, n (%) | 9 (13) | 25 (19) | <.001 |
Use of MAP, n (%) | 7 (11) | 7 (5) | .125 |
Age at the onset of menopause (y), median (min-max) | 44.4 (36-55) | 51.5 (36.2-59) | .006 |